There is a need to develop an open and non-judgmental dialogue between oncologists and cancer patients, addressing the needs of the patient while dealing with issues related to the efficacy and safety of micronutrients.
Referral of patients to an integrative medicine consultant may help achieve these goals, providing both parties with the option of reaching an informed and respectful decision about treatment.
The most common types of malignancy include colorectal cancer, lung cancer, and, depending on gender, breast or prostate cancer.
The corresponding estimates for total cancer deaths in 2012 were 8.2 million.
The pathogenesis of cancer-associated malnutrition is multifactorial.
The review is by no means exhaustive, but presents a selection of the latest findings on important micronutrients used in complementary oncology.There is a better response to the cancer therapy, which in turn improves the prognosis and also the patient’s quality of life [4,11,12,13].The micronutrients used in complementary oncology have to be selected appropriately and taken at the right time so as not to reduce the effects of the cytoreductive therapy [4,5,11].This in turn impacts the patient’s quality of life and the prognosis [9,15,17].Cancer patients with deficient diets have a higher morbidity and mortality: the mortality in malnourished cancer patients is about 30% higher [18,19,20,21,22,23].
Cancers related to these factors, such as breast, lung, and colorectal cancers, are already on the rise in economically-transitioning countries [1,2].